OR WAIT 15 SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
March 02, 2021
Overcoming time and cost constraints can help enable seed train intensification efforts to maximize product yield.
March 01, 2021
While manufacturing increases have been implemented for vials and syringes, meeting future market needs remains unpredictable.
February 16, 2021
The VerderFlex Vantage 5000 peristaltic pump is suitable for low to medium flow at low to medium pressures.
January 01, 2021
Cytiva’s new facility in Shrewsbury, MA will make equipment such as single-use bioreactors.
December 02, 2020
The investment will expand and upgrade manufacturing capacity and technology for pre-fillable syringes and will also includes a new manufacturing facility in Europe.
November 23, 2020
The new super plant, being built in Incheon, South Korea, will have a total biopharmaceutical manufacturing capacity of 256,000 L.
The agreement follows a recent announcement that Sartorius plans to invest $100 million in Songdo, South Korea’s bio cluster.
October 16, 2020
The new facility at the company’s San Diego, CA, site will be for late phase and commercial CGMP manufacturing.
October 15, 2020
Cytiva will provide the first FlexFactory to be used in the manufacture of pDNA to Akron Bio.
September 14, 2020
The investment will include new manufacturing lines and increased automation to deliver additional manufacturing capacity.